GlassScriptPhysician profile
Melanie Ruyle Lerew
NPI 1073824983
$2,627.67
in general payments reported to CMS, 2019-2025
27 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.26 · 2020: $255 · 2021: $144 · 2022: $505 · 2023: $609 · 2024: $379 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532 · Education: $99.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.46 |
| Education | $99.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $830.50 | 2020-2025 | Dupixent |
| Genzyme Corporation | $340.99 | 2020-2025 | |
| Stryker Corporation | $168.52 | 2019-2020 | |
| Optinose US, INC. | $157.46 | 2020-2022 | |
| Neurent Medical Limited | $145.64 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Takeda Pharmaceuticals U.S.A., INC. | $145.41 | 2021-2023 | Cuvitru |
| Glaxosmithkline, LLC. | $132.50 | 2022-2025 | Nucala |
| Medtronic, INC. | $91.26 | 2024-2025 | Bizact, Propel |
| Kaleo, INC. | $85.27 | 2022 | |
| Inspire Medical Systems, INC. | $80.78 | 2023-2024 | Inspire |
| Acclarent, INC | $65.72 | 2023 | Acclarent Aera |
| Merck Sharp & Dohme LLC | $53.13 | 2023-2025 | Keytruda |
| Smith+Nephew, INC. | $42.55 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $31.84 | 2021 | |
| Blueprint Medicines Corporation | $30.59 | 2025 | Ayvakit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $25.53 | 2019 | |
| Olympus America INC. | $24.10 | 2024 | Connecting Tube |
| Novartis Pharmaceuticals Corporation | $22.67 | 2019 | |
| Csl Behring | $21.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.63 | 2025 | Tezspire |
| Aerin Medical INC. | $20.13 | 2022 | |
| Cook Medical LLC | $17.04 | 2023 | Biodesign |
| Genentech USA, INC. | $16.75 | 2019 | |
| Ibsa Pharma INC. | $15.43 | 2022 | |
| Cochlear Americas | $15.09 | 2020 | |
| Tactile Systems Technology INC | $13.62 | 2020 | |
| Alk-Abello, INC | $13.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Lerew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.